key: cord-1021829-4kksig40 authors: Xie, Han; Ying, Hao title: Is the conclusion available? Letter to the Editor concerning the study of Prof. Jin titled “Clinical features and outcomes of pregnant women suspected of coronavirus disease 2019” date: 2020-06-03 journal: J Infect DOI: 10.1016/j.jinf.2020.05.076 sha: 90ed1c299e243c27870c0f3dcb4a42e1b0a5abdb doc_id: 1021829 cord_uid: 4kksig40 nan , especially the significance of pulmonary CT scan plus blood routine examination for screening COVID-19. Due to the worldwide outbreak of infection in the past few months, there were quite a number of urgent hospital admissions for delivery, many effective measures have been taken to reduce the incidence of nosocomial infection and the expansion of the epidemic. We are glad to see that the study investigators including Prof. Jin have strictly implemented the isolation protocol, and established the exact procedure for the patients to be diagnosed and referred actively, which has minimized the adverse prognosis and prevented further spreading of virus, thus protecting mothers and infants against COVID-19 infection. This is an extremely commendable achievement. However, we were a little puzzled about the conclusion from the results. The results showed that, there was no statistical difference between the confirmed COVID-19 group and the control group (p > 0.05) for the imaging of pulmonary CT scan, blood routine examination, and clinical symptoms. These results may lead to the conclusion from this retrospective analysis that the clinical symptoms and laboratory indicators were not obvious for asymptomatic and mild COVID-19 pregnant women. Nevertheless, these results didn't support the conclusion that "Pulmonary CT scan plus blood routine examination are more suitable for finding pregnancy women with asymptomatic or mild COVID-19 infection and can be used screening COVID-19 pregnant women in the outbreak area of COVID-19 infection." The effectiveness of a test method should be evaluated between the outcome of the population who have been screened versus who have not been screened. Effective screening methods usually have higher sensitivity, which is a higher diagnosis rate in the screened population and a lower missed diagnosis in the nonscreened population 2 . In this paper, however, the confirmed group has included the patients with positive sever acute respiratory syndrome coronavirus 2(SARS-CoV-2) via maternal throat swab test, while the control group included the patients already ruled out of COVID-19. Additionally, all the patients in each group have experienced pulmonary CT scan, blood routine examination and assessment of symptoms, while no patient without these screening methods have been included in this study. Therefore, the effectiveness of the screening method has not been properly evaluated. We considered, based on the results that, there was no statistical difference between the confirmed COVID-19 group and the control group in the imaging of pulmonary CT scan, blood routine examination, and clinical symptoms, the conclusion might be: The clinical symptoms and laboratory indicators were not obvious for asymptomatic and mild COVID-19 pregnant women. These screening methods cannot effectively distinguish between asymptomatic or mild confirmed cases and suspected patients. Therefore, strict isolation measures and procedures and early diagnosis for suspected pregnant women are essential in the epidemic area. This is exactly what the author has implemented and already achieved, like many other obstetricians 3-6 . It will also provide helpful information for other obstetricians who are currently experiencing the outbreak of COVID-19. In addition, there were two important items missing in this paper, which might lead to the discrepancy of the results. (1) What is the inclusion criteria in "Study design and patients"? (2) What is the definition of "suspected cases"? According to the original manuscript "The suspected cases of COVID-19 infection were screened based on pulmonary CT scan and routine blood test in combination with symptoms such as fever, cough, chest tightness or gastrointestinal symptoms, and admitted to an isolated suite in our hospital." It would be better for the authors to clarify were these items the inclusion criteria or the observed indicators? If pulmonary CT scan and routine blood test combination with symptoms have been the inclusion criteria, then what kind of testing results should be defined as suspected cases for the study, and what kind of patients need to do the pulmonary CT scan? Because we noticed that not all symptoms, images of pulmonary CT scan and blood indexes were positive in the study results. According to the disease situation at that time, we speculated that the inclusion criteria might be the definition of suspected cases in Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7) (Box 1) 7 . If these definitions of suspected cases have been used as the inclusion criteria, all of the 55 suspect patients in this paper were suffering from at least two of the clinical manifestations. Was it appropriate to use these inclusion criteria as observation indicators at the same time? Furthermore, many studies have suggested the importance of pulmonary CT scan for the screening and the diagnosis of COVID-19 8 . However, the sensitivity of CT scan results has been largely affected by the disease severity, the proportion of patients with comorbidities, and the proportion of asymptomatic patients 9 . This may explain why there was no significant difference about the imaging of pulmonary CT scan between two groups in this paper, since the confirmed group had much less patients than the control group, and many of them were asymptomatic or mild patients. However, can we suggest the author to explore the different combinations of CT, blood test and symptom as the observation index? Probably a screening model with a higher diagnosis rate could https://doi.org/10.1016/j.jinf.2020.05.076 0163-4453/© 2020 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Letter to the Editor / Journal of Infection 81 (2020) e130-e131 e131 be established to further improve the efficiency and quality of screening. Finally, we would appreciate Jin et al. for their original work, but further rigorous design and logical conclusion are still required. Considering both the following epidemiological history and clinical manifestations: Clinical features and outcomes of pregnant women suspected of coronavirus disease 2019 Interferon-gamma release assay for tuberculosis screening of solidorgan transplant recipients is cost-effective Early diagnosis and rapid isolation: response to COVID-19 outbreak in Korea Inpatient Care of Patients with COVID-19: A Guide for Hospitalists Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know Coronavirus Disease 2019 (COVID-19) and Pregnancy: Responding to a Rapidly Evolving Situation Guidelines for the diagnosis and treatment of coronavirus disease 2019 (trial version 7). (Released by National Health Commission & State Administration of Traditional Chinese Medicine on COVID-19 diagnostic process in mainland China: the math beyond pneumonia Diagnostic Performance of CT and Reverse Transcrip-tasePolymerase Chain Reaction for Coronavirus Disease 2019: A Meta-Analysis The authors declare that there are no conflicts of interest.